OpenLegislation

Paragraph 105 I1

United Kingdom

In regulation 137 (amendment of regulation 171 (exempt advanced therapy medicinal products)), for “substitute “regulation 49(1)”.” substitute—

“substitute—

“(i)

in the case of a product for sale or supply in Northern Ireland, Regulation (EC) No 726/2004, and

(ii)

in the case of a product for sale or supply in Great Britain, regulation 49(1).”.”.

Annotations

Commencement

I1

Sch. 2 para. 105 in force at 31.12.2020 immediately before IP completion day, see reg. 1